Drug Type Interleukins |
Synonyms + [1] |
Target |
Mechanism IL1R1 antagonists(Interleukin-1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | CN | 05 Dec 2017 | |
Toxicity due to chemotherapy | Phase 3 | CN | 17 Apr 2017 | |
Drug-induced diarrhea | Phase 2 | CN | 29 Sep 2022 | |
Arthritis, Gouty | Phase 2 | CN | 18 Aug 2022 | |
Colorectal Cancer | Phase 2 | CN | 24 Jun 2019 |